PubMed · 11854482
Optimizing bioconversion pathways through systems analysis and metabolic engineering.
Abstract
We demonstrate a general approach for metabolic engineering of biocatalytic systems comprising the uses of a chemostat for strain improvement and radioisotopic tracers for the quantification of pathway fluxes. Flux determination allows the identification of target pathways for modification as validated by subsequent overexpression of the corresponding gene. We demonstrate this method in the indene bioconversion network of Rhodococcus modified for the overproduction of 1,2-indandiol, a key precursor for the AIDS drug Crixivan.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Daniel E Stafford, Kurt S Yanagimachi, Philip A Lessard, Sushil K Rijhwani, Anthony J Sinskey, Gregory Stephanopoulos. 2002-02-19. Optimizing bioconversion pathways through systems analysis and metabolic engineering.. https://doi.org/10.1073/pnas.032681699
Cite the original work for its findings. Save a collection to share your selection of sources.